{
  "docId": "019de073-a711-71bb-a4fc-67d28d18b8d8",
  "docSlug": "26ea3d305f04fe3e604b448e70b259ea",
  "documentTitle": "BenevolentAI | Investor Presentation Deck | 46 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 46,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "dense",
  "nDataPoints": 30,
  "notes": "The slide uses two charts to show market growth and pipeline maturity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a711-71bb-a4fc-67d28d18b8d8/30",
  "deckHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8",
  "deckJsonHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8.json",
  "deckAnchorHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.55,
        "y": 0.2
      },
      "kind": "chart",
      "text": "AI-drug discovery companies' internal pipelines",
      "attrs": null,
      "subkind": "area",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f627743-a220-404d-afb9-76f034ed36c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Significant investment fuels massive growth for the AI market in drug discovery & development",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db8d3632-70a7-4e84-a4be-4f27cfdb7323",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "This progress has been underpinned by three trends - advances in machine learning techniques, greater availability of biomedical data, increase in computational power",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3de63d54-126f-40d6-b8e0-16de72323ac4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Source: RBC Capital Markets; Emersion Insights. Capital includes funds from private investors, VC and corporate investment funds. Company Websites and press releases. Jayatunga et al. Nat Rev Drug Discov 2022: Number of annual R&D programmes and assets over time, showing the growth of AI-enabled drug discovery. Note: Categories are mutually exclusive. Investment includes equity, Partnerships/collaborations and acquisitions",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6080e4d5-e353-4d59-a59a-b4b9858b6e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "AI is becoming a validated approach in Pharma",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b6b3925-a0eb-447a-9940-f58cd76de790",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "argument-from-analogy",
      "slug": null,
      "matchId": "aaf4de7f-cc59-4405-9013-41abbab1812a",
      "evidence": "Uses market growth and pipeline data to argue for the validation of AI in pharma.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 30,
      "beatId": "fad9bb66-5ad4-437c-a1f9-b7cffca66153",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "AI is becoming a validated approach in Pharma",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 30,
      "from": 30,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "8679e5be-882f-4e5c-a63e-fc08674ef40d",
      "evidence": "AI is becoming a validated approach in Pharma",
      "position": 2,
      "objective": "Why is now the right time for AI-enabled drug discovery?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}